Aspergillus fumigatus secondary metabolite pyripyropene is important for the dual biofilm formation with Pseudomonas aeruginosa
mBio · 2025
DOI: 10.1128/mbio.00363-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, 2025. Verfasst von Patricia Alves de Castro und 15 weiteren Autor:innen. Beteiligte Einrichtung: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil. Hauptthemen laut MEDLINE: Biofilms, Aspergillus fumigatus, Pseudomonas aeruginosa, Secondary Metabolism. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP).
Abstract (Originalsprache)
The human pathogenic fungus Aspergillus fumigatus establishes dual biofilm interactions in the lungs with the pathogenic bacterium Pseudomonas aeruginosa . Screening of 21 A . fumigatus null mutants revealed seven mutants (two G protein-coupled receptors, three mitogen-activated protein kinase receptors, a Gα protein, and one histidine kinase receptor) with reduced biofilm formation, specifically in the presence of P. aeruginosa . Transcriptional profiling and metabolomics analysis of secondary metabolites produced by one of these mutants, Δ gpaB ( gpaB encodes a Gα protein), showed GpaB controls the production of several important metabolites for the dual biofilm interaction, including pyripyropene A, a potent inhibitor of mammalian acyl-CoA cholesterol acyltransferase. Deletion of pyr2 , encoding a non-reducing polyketide synthase essential for pyripyropene biosynthesis, showed reduced A. fumigatus Δ pyr2-P. aeruginosa biofilm growth, altered macrophage responses, and attenuated mouse virulence in a chemotherapeutic murine model. We identified pyripyropene as a novel player in the ecology and pathogenic interactions of this important human fungal pathogen. IMPORTANCE Aspergillus fumigatus and Pseudomonas aeruginosa are two important human pathogens. Both organisms establish biofilm interactions in patients affected with chronic lung pulmonary infections, such as cystic fibrosis (CF) and chronic obstructive pulmonary disease. Colonization with A. fumigatus is associated with an increased risk of P. aeruginosa colonization in CF patients, and disease prognosis is poor when both pathogens are present. Here, we identified A. fumigatus genetic determinants important for the establishment of in vitro dual A. fumigatus-P. aeruginosa biofilm interactions. Among them, an A. fumigatus Gα protein GpaB is important for this interaction controlling the production of the secondary metabolite pyripyropene. We demonstrate that the lack of pyripyropene production decreases the dual biofilm interaction between the two species as well as the virulence of A. fumigatus in a chemotherapeutic murine model of aspergillosis. These results reveal a complete novel role for this secondary metabolite in the ecology and pathogenic interactions of this important human fungal pathogen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.
- Instituto de Química, Universidade Estadual de Campinas, Campinas, Brazil.
- Hospital São Paulo, Vila Clementino, São Paulo, Brazil.
- Departamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
- Department of Bacteriology, Jikei Center for Biofilm Science and Technology, Laboratory of Amyloid Regulation, The Jikei University School of Medicine, Tokyo, Japan.
- Microbiology Research Center for Sustainability (MiCS), Faculty of Life and Environmental Sciences, University of Tsukuba, Tsukuba, Japan.
ORCID-Profile: Patricia Alves de Castro, Daniel Yuri Akiyama, Shinya Sugimoto, Stephen K Dolan, Antonis Rokas, Taícia Fill, Gustavo H Goldman
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
- NIAID NIH HHS
Zitieren
APA
de Castro, P. A., Akiyama, D. Y., Pinzan, C. F., Dos Reis, T. F., Delbaje, E., Rocha, P., Izidoro, M. A., Schenkman, S., Sugimoto, S., Takeshita, N., Steffen, K., Aycock, J. L., Dolan, S. K., Rokas, A., Fill, T., & Goldman, G. H. (2025). Aspergillus fumigatus secondary metabolite pyripyropene is important for the dual biofilm formation with Pseudomonas aeruginosa. mBio. https://doi.org/10.1128/mbio.00363-25
Vancouver
de Castro PA, Akiyama DY, Pinzan CF, Dos Reis TF, Delbaje E, Rocha P, et al. Aspergillus fumigatus secondary metabolite pyripyropene is important for the dual biofilm formation with Pseudomonas aeruginosa. mBio. 2025. doi:10.1128/mbio.00363-25
BibTeX
@article{deCastro2025,
author = {de Castro, Patricia Alves and Akiyama, Daniel Yuri and Pinzan, Camila Figueiredo and Dos Reis, Thaila Fernanda and Delbaje, Endrews and Rocha, Peter and Izidoro, Mario Augusto and Schenkman, Sérgio and Sugimoto, Shinya and Takeshita, Norio and Steffen, Karin and Aycock, Jessica L and Dolan, Stephen K and Rokas, Antonis and Fill, Taícia and Goldman, Gustavo H},
title = {Aspergillus fumigatus secondary metabolite pyripyropene is important for the dual biofilm formation with Pseudomonas aeruginosa},
journal = {mBio},
year = {2025},
doi = {10.1128/mbio.00363-25}
}
EUVIMED